Mathematical models for human cancer incidence rates - Application to results from Europe, including North Cyprus

Asian Pacific Journal of Cancer Prevention

Volumn 10, Issue 2, 2009, Pages 325-335

  Hinçal, Evren ^a  

^a NEAR EAST UNIVERSITY   (Turkey)

Author keywords

Age dependence; Cancer incidence; Mathematical models

Indexed keywords

EID: 67650914902     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Anstey KJ, Lord SR, Smith GA (1996). Measuring human functional age: a review of empirical findings. Exp Aging Res, 22, 245-66.
2. Armitage P, Doll R (1954). The age distribution of cancer an d a multistage theory of carcinogenesis. Br J Cancer, 8, 1-12.
3. Benson D, Mitchell N, Dix D (1996). On the role of aging in carcinogenesis. Mutat Res, 356, 209-216.
4. Cheron G, Desmedt JE (1980). Peripheral and central somatosensory pathways and evoked cerebral potentials during aging. Rev Electroencephalogr Neurophysiol Clin, 10, 146-52.
5. Dean W (1988). Biological Aging Measurement. Los Angeles: The Center Biogerontology.
6. Dix D (1989). The role of aging in cancer incidence: an epidemiological study. J Gerontol, 44, 10-8.
7. European Network of Cancer Registries, EUROCIM Version 4.0. European Incidence Database V2.3, Lyon, ENCR, 2001.
8. Ferlay FJ, Parkin DM.Pisani P (1988). GLOBOCAN 1. Cancer Incidence, Morality and Prevalence Worldwide, Version 1.0. IARC Cancer Base No: 3. Lyon, IARC Press.
9. Grove G, Kilgman A (1983). Age-associated changes in human epidermal cell renewal. J Geront, 38, 137-42.
10. Keogh E, Walsh R (1965). Rate of graying of human hair. Nature, 207, 877-8.
11. Krtolica A, Campisi J (2002). Cancer and aging: a model for the cancer promoting effects of the aging stroma. Int J Biochem Cell Biol, 34, 1401.
12. Kuramoto K, Matsushita S, Esaki Y, Shimada H (1993). Prevalence, rate of correct clinical diagnosis and mortality of cancer in 4,894 elderly autopsy cases. Nippon Ronen Igakkai Zasshi, 30, 35-40.
13. McClearn GE (1997). Bio-markers of age and aging. Exp Gerontol, 32, 87-94.
14. Moolgavkar SH, Venzon DJ (1979). Two-event models for carcinogenesis: incidence curves for childhood and adult tumors. Math Biosci, 47, 55-77.
15. Moolgavkar SH, Knudson AG (1981). Mutation and cancer: a model for human carcinogenesis. J Natl Cancer Inst, 66, 1037-52.
16. Moolgavkar SH, Luebeck EG (1990). Two-event model for carcinogenesis: biological, mathematical and statistical considerations. Risk Anal, 10, 323-41.
17. Moolgavkar SH, Krewski D, Zeise L, Cardis E, Møller H (1999). Quantitative Estimation and Prediction of Human Cancer Risks. Lyon: IARC Sci Publication.
18. Nakamura E, Lane M, Roth G, Ingram D (1998). A strategy for identifying bio-markers of aging. Exp Gerontology, 33, 4.
19. Peto R, Roe FJ, Lee PN, Levy L, Clack J (1975). Cancer and ageing in mice and men. Br J Cancer, 32, 411-26.
20. Peto R, Parish SE, Gray RG. (1985). There is no such thing as ageing, and cancer is not related to it. IARC Sci Publ, 58, 43-53.
21. Pompei F, Polkanov M, Wilson R (2001). Age distribution of cancer in mice: the incidence turnover at old age. Toxicol Ind Health, 17, 7-16.
22. Rainsford J, Cohen P, Dix D (1985). On the role of aging in cancer incidence: analysis of the lung cancer data. Anticancer Res, 5, 427-30.
23. Remmen H, Ward W, Sabia R, Richardson A (1995). Gene expression and protein degradation. In: Masoro E (ed). Handbook of Physiology: Section 11, Aging. New York: Oxford Univ. Press: 171.
24. Riggs JE, Millecch ia RJ (1992). Using the Gompertz-Strehler Model of aging and mortality to explain mortality trends in industrialized countries. Mech Aging Develop, 65, 217-28.
25. Riggs JE, Hobbs GR (1998). Non random sequence of slope-intercept estimates in longitudinal Gompertzian analysis suggests biological relevance. Mech Aging Develop, 100, 269-75.
26. Robertson C, Gandini S., Boyle P. (1999). Age-period-cohort models: a comparative study of available methodologies. J Clin Epidemiol, 52, 569-83.
27. Rubin H. (1997). Cell aging in vivo and in vitro. Mech Aging Develop, 98, 1-35.
28. Smith D. (1996). Cancer mortality at very old ages. Cancer, 77, 1367-72.
29. Smith D. (1999). Resistance to causes of death: a study of cancer mortality resistance in the oldest old. In: Robine JM et. al. (Eds). The Paradoxes of Longevity. Springer-Verlag: 61-71.
30. Sohal R, Weindruch R (1996). Oxidative stress, caloric restriction, and aging. Science, 273, 59-63.
31. Stanta G, Campagner L, Cavallieri F, Giarelli L (1997). Cancer of the oldest old. What we have learned from autopsy studies. Clin Geriatr Med, 13, 55-68.
32. Strehler B (1962). Time, Cells, and Aging. London: Academic Press.
33. Strehler BL, Mildvan AS (1960). General theory of mortality and aging. Science, 132, 14-21.
34. Turkish Republic of Northern Cyprus (TRNC) Statistical Year Book, State Planning Organization, Statistics and Research Department, 1999, 2001, 2002 and 2005
35. Turkish Republic of Northern Cyprus (TRNC) Ministry of Health, NCCR: http: www.saglikbakanligi.com
36. Ukraintseva SV, Yashin AI (2001). How individual aging may influence human morbidity and mortality patterns. Mech Aging Dev, 122, 1447-60.
37. Ukraintseva SV., Yashin AI (2003). Individual aging and cancer risk: How are they related? Demograph Res, 9, 163-96.
38. Van Leeuwen IMM, Zonneweld C (2001). From exposure to effect: a comparison of modeling approaches to chemical carcinogenesis. Mutat Res, 489, 17-45.
39. Vaupel JW, Manton KG, Stallard E (1979). The impact of heterogeneity in individual frailty on the dynamics of mortality. Demography, 16, 439-54.
40. Vaupel JW, Yashin AI (1985). Heterogeneity's ruses: some surprising effects of selection on population dynamics. Am Statistician, 39, 176-84.
41. Vaupel JW, Yashin AI (1988). Cancer Rates over Age, Time, and Place: In sights from Stochastic Models of Heterogeneous Populations. WP #88-01-1 of the Center for Population Analysis and Policy, University of Minnesota, and MPIDR Working Paper WP 1999-006.
42. Volpe EW, Dix D (1986). On the role of aging in cancer incidence: cohort analyses of the lung cancer data. Anticancer Res, 6, 1417-20.
43. Yakovlev AY, Asselain B, Bardou V-J, Fourquet A, Hoang T, Rochefodiere A,Tsodikov AD (1993). A simple stochastic model of tumor recurrence and its application to data on pre-menopausal breast cancer. ??
44. Yakovlev AY, Tsodikov AD (1996). Stochastic Models of Tumor Latency and their Bio-statistical Applications. Singapore: World Scientific.